Chapman MJ, Jones KL, Almansa C, Barnes CN, et al. Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to
Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4
Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance. JPEN J Parenter Enteral Nutr 2020 Jan 28. doi: 10.1002/jpen.1732.
PMID: 31990087